皮纹与疾病的遗传学纽带:GWAS 共定位能否证明\u201c手相\u201d与疾病风险共享同一基因?

Written by

in

Language

Evidence level: B

皮纹与精神分裂、高血压的关联时有时无,共定位分析提供了一条更硬的检验路径:如果皮纹 GWAS 位点与疾病风险位点共享同一因果变异,\u201c手相\u201d与疾病风险的关联就有一条可证伪的遗传学通道,而不是统计噪声。

正文

手相在传统命理体系里地位特殊——掌纹、指纹被当作\u201c一生的密码\u201d来解读。现代科学对这件事的态度经历过一个反转:最初认为皮纹与疾病相关是伪科学,但近十年的基因组学研究给出一个意外的中间答案——皮纹确实是\u201c读得出信息\u201d的生物标记,只是读出的不是命运,而是胚胎期的发育轨迹。问题在于,皮纹与精神分裂、高血压这类疾病的关联,在文献里忽左忽右:精神分裂症的 meta 分析反复报告患者 a-b 脊数显著降低,高血压研究则发现斗型纹频率与总脊线数偏高;可双生子研究又报告两者毫无关联。同一个指标,为什么结论如此不稳定?

2022 年发表于《细胞》的一项里程碑研究改变了讨论的层次。研究者对 2.3 万余名个体的全基因组扫描与跨族裔荟萃分析,识别出 43 个与指纹花纹相关的遗传基因座,并通过小鼠功能实验证实关键基因 EVI1 通过调控肢体发育——而非皮肤发育——塑造指纹模式。这项研究最重要的发现是:指纹相关基因显著富集在肢体发育通路,而这些发育基因在人体发育中普遍扮演\u201c一因多效\u201d(pleiotropy)角色——同一个基因影响多个看似无关的表型。这正是皮纹与疾病可能共享遗传基础的机制学入口:如果决定皮纹的基因同时参与神经或心血管发育,皮纹表型与疾病风险就会在遗传层面\u201c藕断丝连\u201d。

这种\u201c丝\u201d已经有直接证据。2025 年的一项家族研究在 61 个精神分裂谱系核心家庭中发现,DISC1 基因的 rs999710 变异与皮纹偏离标记(指嵴数降低、ATD 角增大)共同传递给患病后代,且 BDNF、NOS1AP、RGS4 等缺氧敏感基因对这种共传递有叠加效应——这是\u201c皮纹-精神分裂共享遗传通路\u201d最直接的分子证据。血压侧虽老但同样关键:1993 年 BMJ 研究随访 139 名 50 年前有出生记录的个体,发现带斗型纹者收缩压平均高 8 mmHg,且斗型纹越多血压越高;而双生子研究给出相反结论,提示这类关联可能受样本量与混杂因素影响。

要分清\u201c真共享\u201d与\u201c假相关\u201d,标准工具是共定位分析(colocalization)。它用贝叶斯框架检验同一基因组区域的两个 GWAS 信号是否源于同一因果变异——如果皮纹 GWAS 的峰值位点与精神分裂或高血压 GWAS 的峰值位点在同一个 LD 区间内\u201c共定位\u201d,就说明两个表型共享同一遗传开关,而不是连锁不平衡造成的巧合。方法学已经成熟:coloc 包的标准化流程(PMID 36515558)、整合 GWAS 与 eQTL 的三类检测方法综述(PMID 38568343)、以及整合 3000 余个 GWAS 汇总数据的 COLOCdb 数据库(PMID 37941154)——皮纹侧只需要补上自己的 GWAS 汇总统计量,即可对全部 43 个指纹位点做系统性筛查。

需要强调的是,共定位能证明\u201c共享因果变异\u201d,但共享一个变异不等于共享一份命运——发育基因在胚胎期同时参与皮纹与神经、血管成型,出生后皮纹定型,疾病却还要叠加几十年环境与随机性。所以即使共定位全部命中,皮纹也只是一个微弱的发育印记,绝非\u201c看手相算命\u201d。这条研究路径的真正价值在于:它把传统相学里\u201c掌纹藏信息\u201d的直觉,翻译成可计算、可证伪的遗传学问题。

由此推出可检验命题:其一,全基因组层面皮纹位点与精神分裂/高血压位点的共定位筛查——精神分裂侧有 DISC1 家族证据铺垫,预期命中率最高;高血压侧文献矛盾,正好用共定位裁决\u201c真共享还是噪声\u201d。其二,EVI1 通道验证——EVI1 已知与白血病相关,而 Cell 研究提示斗型纹多者白血病易感,这是一条从皮纹到血液系统疾病的完整多效性链条,可优先做共定位加孟德尔随机化的双方法验证。其三,跨族裔重复——皮纹 GWAS 位点多为东亚人群发现,需要在欧洲与非洲裔人群中验证共定位信号是否稳定。

证据与局限

已验证: 指纹 GWAS 识别 43 个位点、富集肢体发育通路、EVI1 经小鼠功能验证(PMID 34995520);DISC1-rs999710 与皮纹偏离标记在精神分裂家族中共传递(PMID 41037940);斗型纹与收缩压升高相关(PMID 8374451);共定位方法学与资源成熟(PMID 36515558、PMID 38568343、PMID 37941154)。

部分验证: 皮纹-精神分裂关联经 83 项研究综述确认为稳定的神经发育标记(PMID 41281513),但效应量小、机制不明;皮纹-高血压关联存在方向矛盾(双生子研究阴性,PMID 7594415)。

待验证: 皮纹位点与疾病位点的全基因组共定位筛查尚无大样本直接检验;EVI1-白血病多效性通道待验证;共定位信号的跨族裔稳定性未知。

相关阅读

证据等级: B
参考文献: PMID 34995520, PMID 41037940, PMID 41281513, PMID 8374451, PMID 7594415, PMID 36515558, PMID 38568343, PMID 37941154


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Genetic Link Between Dermatoglyphics and Disease: Can GWAS Colocalization Prove That \”Handwriting\” Shares Genes with Disease Risk?

Evidence level: B

The association between dermatoglyphics and conditions such as schizophrenia and hypertension fluctuates across studies. Colocalization analysis offers a more rigorous testing pathway: if dermatoglyphic GWAS loci share a causal variant with disease risk loci, the link between “palmar lines” and disease risk possesses a falsifiable genetic channel rather than being mere statistical noise.

Main Text

In traditional Yijing Studies, palm lines hold a unique status—palmar patterns and fingerprints are interpreted as the “code of a lifetime.” Modern science has undergone a reversal regarding this topic: initially dismissed as pseudoscience, recent genomic research over the past decade offers an unexpected intermediate answer—dermatoglyphics are indeed biological markers that “carry information,” but they do not read destiny; rather, they reflect embryonic developmental trajectories. The issue lies in the instability of findings: meta-analyses on schizophrenia repeatedly report a significant reduction in ridge counts at the a-b junction, while hypertension studies find higher frequencies of whorls and total ridge counts. Yet, twin studies report no association at all. Why do conclusions regarding the same metric remain so unstable?

A landmark study published in Cell in 2022 elevated the discourse. Researchers performed a whole-genome scan and cross-ethnic meta-analysis on over 23,000 individuals, identifying 43 genetic loci associated with fingerprint patterns. Crucially, functional experiments in mice confirmed that the key gene EVI1 shapes fingerprint patterns by regulating limb development—rather than skin development. The most significant finding was that genes associated with fingerprints are significantly enriched in limb developmental pathways. These developmental genes universally play a “pleiotropic” role in human development—meaning a single gene influences multiple seemingly unrelated phenotypes. This represents the mechanistic entry point for how dermatoglyphics and disease might share a genetic basis: if genes determining fingerprint patterns also participate in neural or cardiovascular development, the dermatoglyphic phenotype and disease risk will be “genetically intertwined.”

There is already direct evidence for this “thread.” A 2025 family study identified in 61 core families within the schizophrenia spectrum that the DISC1 gene variant rs999710 is co-transmitted with dermatoglyphic deviation markers (reduced ridge counts, increased ATD angle) to affected offspring. Furthermore, hypoxia-sensitive genes such as BDNF, NOS1AP, and RGS4 exhibit additive effects on this co-transmission—providing the most direct molecular evidence for a “dermatoglyphics-schizophrenia shared genetic pathway.” On the hypertension side, while older, the 1993 BMJ study remains critical: following up on 139 individuals with birth records from 50 years prior, it found that those with whorls had an average systolic blood pressure 8 mmHg higher, with higher whorl counts correlating with higher blood pressure. Conversely, twin studies reported no association, suggesting these links may be influenced by sample size and confounding factors.

To distinguish “true sharing” from “false correlation,” the standard tool is colocalization analysis. It employs a Bayesian framework to test whether two GWAS signals in the same genomic region originate from the same causal variant. If the peak loci for dermatoglyphics in GWAS “colocalize” with peak loci for schizophrenia or hypertension within the same linkage disequilibrium (LD) interval, it indicates that the two phenotypes share a single genetic switch rather than coincidental linkage disequilibrium. Methodological maturity is established: standardized workflows for the coloc package (PMID 36515558), reviews of three detection methods integrating GWAS and eQTL (PMID 38568343), and the COLOCdb database integrating over 3,000 GWAS summary statistics (PMID 37941154). On the dermatoglyphic side, researchers only need to supplement their own GWAS summary statistics to systematically screen all 43 fingerprint loci.

It must be emphasized that colocalization can prove “shared causal variants,” but sharing a variant does not equate to sharing a fate. Developmental genes participate in both fingerprint formation and neural/vessel formation during embryogenesis; fingerprints solidify after birth, whereas disease risks accumulate over decades of environmental exposure and randomness. Therefore, even if colocalization hits are universal, dermatoglyphics remain merely a weak developmental imprint, far from being a basis for “reading palms to predict fate.” The true value of this research trajectory lies in translating the intuitive notion from traditional palm reading that “palms conceal information” into calculable, falsifiable genetic questions.

This leads to testable propositions: First, a whole-genome colocalization screening for dermatoglyphic loci against schizophrenia and hypertension loci. Given the DISC1 family evidence on the schizophrenia side, the expected hit rate is highest; the contradictory literature on hypertension provides a precise opportunity for colocalization to adjudicate “true sharing versus noise.” Second, validation of the EVI1 pathway. Since EVI1 is known to be associated with leukemia, and the Cell study suggests a link between whorl counts and leukemia susceptibility, this represents a complete pleiotropic chain from dermatoglyphics to hematological disease, warranting dual-method validation via colocalization and Mendelian randomization. Third, cross-ethnic replication. Most dermatoglyphic GWAS loci were discovered in East Asian populations; it is necessary to verify whether colocalization signals remain stable across European and African populations.

Evidence and Limitations

Verified: Identification of 43 fingerprint GWAS loci enriched in limb developmental pathways and functional validation of EVI1 in mice (PMID 34995520); co-transmission of DISC1-rs999710 with dermatoglyphic deviation markers in schizophrenia families (PMID 41037940); association between whorls and elevated systolic blood pressure (PMID 8374451); maturity of colocalization methodology and resources (PMID 36515558, PMID 38568343, PMID 37941154).

Partially Verified: The dermatoglyphics-schizophrenia association is confirmed as a stable neurodevelopmental marker across 83 studies (PMID 41281513), though effect sizes are small and mechanisms remain unclear; the dermatoglyphics-hypertension association exhibits directional contradictions (negative findings in twin studies, PMID 7594415).

To Be Verified: Whole-genome colocalization screening between dermatoglyphic loci and disease loci lacks large-scale direct testing; the EVI1-leukemia pleiotropic pathway awaits verification; cross-ethnic stability of colocalization signals is unknown.

Related Reading

Evidence Level: B
References: PMID 34995520, PMID 41037940, PMID 41281513, PMID 8374451, PMID 7594415, PMID 36515558, PMID 38568343, PMID 37941154


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *